“Bioeconomy and Life Sciences Development Opportunities in Lithuanian Regions” event tour has successfully reached its end

The event tour of Lithuanian regions “Bioeconomy and Life Sciences Development Opportunities in Lithuanian Regions”, organised by the Lithuanian Biotechnology Association, reached the finnish on the 13th of November. After the first visit to Telsiai, due to the spread the COVID-19 infection, it was decided to transfer the tour events to the remote format, thus…

Northway Biotech opens new biopharmaceutical manufacturing facility in Greater Boston Area

Waltham, MA, US – January 20, 2021 – Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), established in 2004, with an EMA and FDA-compliant, state-of-the-art, cGMP manufacturing site in Europe, announced at the virtual grand opening ceremony today, the opening of its new 30,000 square-foot process development and cGMP manufacturing site in Waltham,…

Northway Biotechpharma announces company name change to Northway Biotech

Vilnius, Lithuania, and Waltham, MA, US – December 9, 2020 – Northway Biotechpharma, providing end-to-end contract drug development and manufacturing (CDMO) services, announces brand name change to Northway Biotech. Along with the tradename change, Dr. Vladas Algirdas Bumelis also returns to the helm as Chief Executive Officer at the company he founded. “We are expanding…

Biomatter Designs raises €500k to develop AI for Generative Protein Design

Computationally engineered enzyme (gray) for enhanced stability, bound to DNA (red). Biomatter Designs raises €500k to develop AI for Generative Protein Design Vilnius-born startup Biomatter Designs that pioneers the technologies for generative protein design, has raised €500,000 in seed funding led by Practica Capital, accompanied by 70V and angel investors. The raised capital will be…

Welcome to our newest members – UAB Bioversija

At the end of this year, company UAB Bioversija joined the Lithuanian Biotechnology Association. UAB Bioversija develops efficient and environmentally sustainable biological products for the agriculture. The aim of the company is searching effective biological alternatives for the chemical products used in agriculture. The products developed by the company’s professionals are based on unique microorganisms…

Lithuanian Biotechnology, Life Sciences Industry and Academia Round-up for 2020

The year of 2020 was different for all of us. The global pandemic affected wide range of industries: biotechnology and natural sciences sectors were no exception. Despite the unusual circumstances this period has served biotechnology industry many opportunities and enabled effective contribution in the global response to the COVID pandemic. Lithuanian biotechnology sector is no…

Congratulations to our new member Centre for Innovative Medicine!

We want to congratulate a new member of LBTA: Centre for Innovative Medicine, who’s membership was approved on the 7 December after the board voting. Centre for Innovative Medicine is a State funded Research Institute where important long-term visions of therapeutic and diagnostic strategies are being implemented and translated from fundamental science into clinically relevant knowledge…

LBTA – is a new member of the Bio-based Industries Consortium (BIC)

In order to actively participate in the development of Lithuanian bioindustry and bioeconomy, Lithuanian biotechnology association decided to join the Bio-based Industries Consortium (BIC). BIC – is a Brussels-based European Bioindustry Consortium, which acts as a private partner in the public and private sector together with the EU’s Bio-based Industries Joint Undertaking (BBI JU). More…

European Digital Innovation Hub (EDIH) for the Vilnius region was nominated for European Commission

The Lithuanian Science and Business Consortium has been nominated for the European Commission as the European Digital Innovation Hub (EDIH) for the Vilnius region! EDIH will provide digitisation and innovation support and advisory services to small and medium-sized enterprises and the public sector by pooling the competences and infrastructure of digital technologies. The European Digital…

The WOMEN IN BIOTECH platform launched during the first cycle of events

Four is that is the number of times American and Lithuanian female biotechnology leaders were greeted by the WOMEN IN BIOTECH audience. The speakers introduced four areas of interest during the virtual events: the biotechnology industry, non-governmental organisations, investing and start-up development. The four remote events attracted a total of nearly 1800 participants. Discussions joined…